Lv1
20 积分 2024-01-19 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
1小时前
待确认
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT
1个月前
已完结
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
3个月前
已完结
Application and evaluation of fecal SDC2 gene methylation in the diagnosis and treatment of colorectal cancer
7个月前
已关闭
LBA40 Primary results from the phase III ALTN-AK105-III-02 study: Anlotinib plus penpulimab versus sorafenib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
7个月前
已关闭
吡柔比星与米托蒽醌用于膀胱癌灌注化疗对血清及灌洗液中恶性分子表达的影响
10个月前
已完结
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study
10个月前
已完结
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
1年前
已完结
Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1
1年前
已完结
皖公网安备34019202002308
